The Beauty Health Company (NASDAQ:SKIN) Receives Consensus Recommendation of “Hold” from Analysts

Shares of The Beauty Health Company (NASDAQ:SKIN) have earned an average rating of “Hold” from the seven research firms that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. The average 1-year price target among brokers that have covered the stock in the last year is $1.38.

SKIN has been the subject of several research analyst reports. Zacks Research downgraded Beauty Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 20th. TD Cowen decreased their target price on Beauty Health from $1.00 to $0.90 and set a “hold” rating on the stock in a research report on Wednesday, August 12th. Finally, Weiss Ratings lowered Beauty Health from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, July 23rd.

Beauty Health Stock Up 0.7%

Shares of NASDAQ SKIN opened at $0.59 on Friday. The company has a quick ratio of 1.48, a current ratio of 1.76 and a debt-to-equity ratio of 4.36. Beauty Health has a 52 week low of $0.55 and a 52 week high of $1.76. The firm has a 50-day moving average price of $0.67 and a 200 day moving average price of $0.75. The stock has a market capitalization of $76.77 million, a price-to-earnings ratio of -2.68 and a beta of 1.05.

Beauty Health (NASDAQ:SKIN) last issued its earnings results on Thursday, August 6th. The company reported ($0.02) earnings per share for the quarter, hitting the consensus estimate of ($0.02). Beauty Health had a negative net margin of 9.79% and a negative return on equity of 47.83%. The company had revenue of $72.11 million for the quarter, compared to analyst estimates of $74.45 million. Equities research analysts anticipate that Beauty Health will post -0.16 EPS for the current fiscal year.

Institutional Investors Weigh In On Beauty Health

Institutional investors and hedge funds have recently made changes to their positions in the business. Diversified Trust Co acquired a new stake in Beauty Health in the 1st quarter valued at about $25,000. Bank of America Corp DE raised its position in Beauty Health by 19.2% during the first quarter. Bank of America Corp DE now owns 106,242 shares of the company’s stock worth $95,000 after acquiring an additional 17,088 shares during the last quarter. Renaissance Technologies LLC lifted its holdings in shares of Beauty Health by 29.6% in the first quarter. Renaissance Technologies LLC now owns 283,791 shares of the company’s stock valued at $253,000 after purchasing an additional 64,900 shares in the last quarter. Finally, Capricorn Fund Managers Ltd purchased a new stake in shares of Beauty Health in the first quarter valued at about $17,270,000. 93.26% of the stock is currently owned by hedge funds and other institutional investors.

About Beauty Health

BeautyHealth is a global health and beauty company focused on creating technology-enabled products and experiences for skin health. Its primary brand is Hydrafacial, which offers non-invasive skin treatments that combine cleansing, exfoliation, extraction and hydration with professional-grade devices, serums and treatment boosters.

The company also provides products and systems designed for complementary aesthetic and wellness applications, including Syndeo, a connected Hydrafacial delivery system; Keravive, a scalp-health treatment; and SkinStylus, a microneedling platform.